4/22
04:05 pm
lfcr
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
4/8
08:13 am
lfcr
Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit [Yahoo! Finance]
Neutral
Report
Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit [Yahoo! Finance]
4/8
08:00 am
lfcr
Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit
Medium
Report
Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit
4/6
08:00 am
lfcr
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCR
Medium
Report
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCR
4/4
08:38 am
lfcr
When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)? [Yahoo! Finance]
Medium
Report
When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)? [Yahoo! Finance]
3/26
04:39 pm
lfcr
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/26
04:05 pm
lfcr
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3/26
07:00 am
lfcr
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
Medium
Report
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
3/24
03:02 pm
lfcr
Lifecore Biomedical (LFCR) had its "outperform" rating reaffirmed by Barrington Research. They now have a $5.50 price target on the stock.
Low
Report
Lifecore Biomedical (LFCR) had its "outperform" rating reaffirmed by Barrington Research. They now have a $5.50 price target on the stock.
3/23
07:00 am
lfcr
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
Low
Report
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
3/20
05:16 pm
lfcr
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029 [Yahoo! Finance]
Low
Report
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029 [Yahoo! Finance]
3/17
08:00 am
lfcr
Lifecore Biomedical (LFCR) was upgraded by Barrington Research from "market perform" to "outperform". They now have a $5.50 price target on the stock.
Low
Report
Lifecore Biomedical (LFCR) was upgraded by Barrington Research from "market perform" to "outperform". They now have a $5.50 price target on the stock.
3/16
04:57 pm
lfcr
Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/16
04:55 pm
lfcr
Lifecore targets 12% revenue CAGR through 2029 as midterm pipeline milestones shift [Seeking Alpha]
Low
Report
Lifecore targets 12% revenue CAGR through 2029 as midterm pipeline milestones shift [Seeking Alpha]
3/16
03:28 pm
lfcr
Lifecore Biomedical Inc (LFCR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Low
Report
Lifecore Biomedical Inc (LFCR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
3/16
11:10 am
lfcr
Lifecore Biomedical Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Lifecore Biomedical Q4 Earnings Call Highlights [Yahoo! Finance]
3/16
08:23 am
lfcr
Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update [Yahoo! Finance]
High
Report
Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update [Yahoo! Finance]
3/16
08:00 am
lfcr
Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update
High
Report
Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update
3/10
04:12 pm
lfcr
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum [Yahoo! Finance]
Low
Report
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum [Yahoo! Finance]
3/10
04:05 pm
lfcr
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum
Low
Report
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum
3/9
04:05 pm
lfcr
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026
Low
Report
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026
3/4
04:15 pm
lfcr
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment [Yahoo! Finance]
Low
Report
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment [Yahoo! Finance]
3/4
04:03 pm
lfcr
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment
Low
Report
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment
2/17
07:30 am
lfcr
Lifecore Biomedical to Participate at DCAT Week 2026 [Yahoo! Finance]
Low
Report
Lifecore Biomedical to Participate at DCAT Week 2026 [Yahoo! Finance]
2/17
07:05 am
lfcr
Lifecore Biomedical to Participate at DCAT Week 2026
Low
Report
Lifecore Biomedical to Participate at DCAT Week 2026